Insider Trading: AMYLIN PHARMACEUTICALS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by
insiders of AMYLIN PHARMACEUTICALS INC since year 2005 are given in the first table.
The second table lists detailed insider transactions reported by AMYLIN PHARMACEUTICALS INC since 2005.
The reporting company's ticker symbol is AMLN .
The reporting company's CIK number is 881464 .
The total value of stock buying during this period is $159,116,436.
The total value of stock sales is $70,875,217.
The total value of stock exercises is $8,052,588.
Figure 1. Monthly insider transaction values at AMYLIN PHARMACEUTICALS INC (AMLN) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
06
07
08
09
10
11
12
01 2007
02
03
04
05
06
07
08
09
10
11
12
01 2008
02
03
04
05
Figure 2. Average prices of insider buys, sales, and option exercises at AMYLIN PHARMACEUTICALS INC (AMLN) in the past 24 months. See table 2 for insider transaction details.
06
07
08
09
10
11
12
01 2007
02
03
04
05
06
07
08
09
10
11
12
01 2008
02
03
04
05
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for AMYLIN PHARMACEUTICALS INC (AMLN ).
Trading Period
Insider Buying
Insider Sales
Option Exercises
2008-05 416,619 11,623,670 0 0 0 0 2008-04 4,502,240 131,997,798 60,000 1,925,627 0 0 2008-03 459,881 12,639,294 0 0 5,608 13,712 2008-02 75,000 2,014,333 8,308 254,052 76,724 326,292 2008-01 0 0 40,100 1,408,347 14,700 105,501 2007-12 0 0 41,100 1,551,661 22,700 148,399 2007-11 0 0 44,600 1,838,206 96,645 443,629 2007-10 0 0 51,800 2,510,265 20,700 214,491 2007-09 0 0 56,100 2,744,801 30,150 303,240 2007-08 0 0 109,914 5,427,321 73,700 858,134 2007-07 0 0 50,892 2,188,124 163,200 582,615 2007-06 0 0 53,892 2,406,651 39,098 486,527 2007-05 0 0 84,618 3,680,033 49,200 571,623 2007-04 0 0 54,738 2,196,800 20,700 118,979 2007-03 0 0 41,892 1,573,320 50,969 482,562 2007-02 0 0 27,892 1,107,178 16,700 140,907 2007-01 0 0 25,192 990,697 133,479 409,497 2006-12 0 0 32,692 1,254,688 29,673 354,844 2006-11 0 0 68,192 2,963,227 17,500 142,860 2006-10 0 0 62,038 2,752,071 17,500 163,627 2006-09 0 0 62,525 2,849,258 18,500 173,178 2006-08 0 0 79,038 3,498,623 21,593 175,978 2006-07 0 0 61,038 2,974,159 8,500 91,455 2006-06 0 0 30,846 1,417,092 18,869 286,120 2006-05 0 0 66,384 2,842,122 18,000 76,947 2006-04 0 0 59,692 2,758,795 23,000 121,572 2006-03 0 0 58,192 2,587,732 19,500 81,128 2006-02 0 0 97,846 3,951,186 54,154 72,276 2006-01 0 0 65,121 2,735,444 100,555 1,086,930 2005-12 0 0 39,940 1,543,914 3,500 19,565 2005-11 0 0 39,692 1,420,951 0 0 2005-10 0 0 34,692 1,215,665 0 0 2005-09 0 0 34,692 1,112,681 0 0 2005-08 0 0 13,538 317,177 0 0 2005-07 0 0 9,192 196,042 0 0 2005-06 0 0 31,692 604,387 0 0 2005-05 50,000 841,341 0 0 0 0 2005-03 0 0 3,846 76,920 0 0
Go to page: 1
2 3 4
Table 2. Detailed insider stock purchases, sales, and option exercises
for AMYLIN PHARMACEUTICALS INC (AMLN )
Trade Date
Insider Name
Trade Type
Shares
Price ($)
Value ($)
2008-05-07 Black Bear Offshore Master Fund Lp Purchase 166,619 27.90 4,648,670 2008-05-07 Eastbourne Capital Management Llc/ca Purchase 250,000 27.90 6,975,000 2008-04-30 Black Bear Offshore Master Fund Lp Purchase 356,652 27.72 9,886,393 2008-04-30 Eastbourne Capital Management Llc/ca Purchase 356,652 27.72 9,886,393 2008-04-21 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 894,000 29.04 25,957,290 2008-04-21 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 894,000 29.04 25,957,290 2008-04-17 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 50,000 30.35 1,517,500 2008-04-17 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 50,000 30.35 1,517,500 2008-04-16 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 19,471 30.78 599,317 2008-04-16 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 19,471 30.78 599,317 2008-04-15 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 28,689 29.27 839,727 2008-04-15 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 28,689 29.27 839,727 2008-04-14 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 147,308 29.42 4,333,310 2008-04-14 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 147,308 29.42 4,333,310 2008-04-11 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 291,300 29.98 8,733,902 2008-04-11 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 291,300 29.98 8,733,902 2008-04-09 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 208,700 30.05 6,271,435 2008-04-09 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 208,700 30.05 6,271,435 2008-04-08 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 50,000 30.96 1,548,000 2008-04-08 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 50,000 30.96 1,548,000 2008-04-07 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 50,000 31.52 1,576,000 2008-04-07 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 50,000 31.52 1,576,000 2008-04-04 Cook Joseph C Jr (Director) Sale 30,000 32.01 960,333 2008-04-03 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 155,000 30.56 4,736,025 2008-04-03 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 155,000 30.56 4,736,025 2008-04-01 Cook Joseph C Jr (Director) Sale 10,000 32.51 325,072 2008-03-28 Black Bear Offshore Master Fund Lp (10% Owner) Purchase 118,933 28.10 3,342,017 2008-03-28 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 118,933 28.10 3,342,017 2008-03-26 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 41,067 28.06 1,152,134 2008-03-25 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 90,000 28.61 2,574,900 2008-03-17 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 60,632 24.50 1,485,484 2008-03-10 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,608 2.45 13,712 2008-02-29 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 50,000 26.59 1,329,333 2008-02-28 Eastbourne Capital Management Llc/ca (10% Owner) Purchase 25,000 27.40 685,000 2008-02-19 Greene Howard E Jr (Director) Sale 3,700 28.74 106,332 2008-02-11 Greene Howard E Jr (Director) Option Exercise 10,000 4.38 43,750 2008-02-05 Cook Joseph C Jr (Director) Option Exercise 66,724 4.23 282,542 2008-02-04 Graham Ginger L (Director) Sale 908 31.98 29,040 2008-02-04 Greene Howard E Jr (Director) Sale 3,700 32.08 118,680 2008-01-22 Baron Alain D (Sr VP Research) Option Exercise 2,000 7.19 14,375 2008-01-22 Cook Joseph C Jr (Director) Sale 10,000 32.60 325,983 2008-01-22 Greene Howard E Jr (Director) Sale 3,700 33.08 122,392 2008-01-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,000 35.42 212,500 2008-01-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,000 1.84 11,061 2008-01-07 Greene Howard E Jr (Director) Sale 3,700 35.55 131,539 2008-01-03 Cook Joseph C Jr (Director) Sale 10,000 36.67 366,681 2008-01-02 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 37.20 249,252 2008-01-02 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 11.95 80,065 2007-12-24 Greene Howard E Jr (Director) Sale 3,700 38.23 141,460 2007-12-20 Baron Alain D (Sr VP Research) Option Exercise 9,000 7.19 64,687 2007-12-18 Cook Joseph C Jr (Director) Sale 10,000 37.72 377,185 2007-12-17 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 38.39 191,950 2007-12-17 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 5.73 28,650 2007-12-10 Greene Howard E Jr (Director) Sale 3,700 39.05 144,503 2007-12-04 Cook Joseph C Jr (Director) Sale 10,000 36.86 368,600 2007-12-03 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 37.56 75,110 2007-12-03 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Exercise 2,000 16.54 33,080 2007-12-03 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 37.74 252,853 2007-12-03 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 3.28 21,982 2007-11-26 Greene Howard E Jr (Director) Sale 3,700 39.05 144,490 2007-11-20 Cook Joseph C Jr (Director) Sale 10,000 38.71 387,061 2007-11-19 Baron Alain D (Sr VP Research) Sale 1,000 40.50 40,500 2007-11-19 Baron Alain D (Sr VP Research) Option Exercise 1,000 18.85 18,850 2007-11-16 Bradbury Daniel (President & Chief Exec Officer) Option Exercise 9,445 14.28 134,884 2007-11-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 41.68 208,392 2007-11-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 5.73 28,650 2007-11-14 Cook Joseph C Jr (Director) Option Exercise 70,000 2.66 185,920 2007-11-12 Greene Howard E Jr (Director) Sale 3,700 40.44 149,610 2007-11-05 Cook Joseph C Jr (Director) Sale 10,000 41.49 414,927 2007-11-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 44.00 22,000 2007-11-01 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400 2007-11-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 44.16 88,311 2007-11-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Exercise 2,000 16.54 33,080 2007-11-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 44.02 294,915 2007-11-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 2.91 19,470 2007-11-01 Baron Alain D (Sr VP Research) Sale 2,000 44.00 88,000 2007-11-01 Baron Alain D (Sr VP Research) Option Exercise 2,000 7.19 14,375 2007-10-29 Greene Howard E Jr (Director) Sale 3,700 46.46 171,913 2007-10-18 Baron Alain D (Sr VP Research) Sale 1,000 45.94 45,940 2007-10-18 Baron Alain D (Sr VP Research) Option Exercise 1,000 18.85 18,850 2007-10-18 Cook Joseph C Jr (Director) Sale 10,000 46.00 459,961 2007-10-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 47.70 238,475 2007-10-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 5.73 28,650 2007-10-15 Greene Howard E Jr (Director) Sale 3,700 47.90 177,223 2007-10-03 Gergen Mark J (Sr VP, Corporate Development) Sale 500 50.00 25,000 2007-10-03 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400 2007-10-03 Baron Alain D (Sr VP Research) Sale 1,000 50.00 50,000 2007-10-03 Baron Alain D (Sr VP Research) Option Exercise 1,000 7.19 7,187 2007-10-03 Cook Joseph C Jr (Director) Sale 10,000 50.17 501,663 2007-10-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 49.83 24,915 2007-10-01 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400 2007-10-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 49.67 99,340 2007-10-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Exercise 2,000 16.54 33,080 2007-10-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 49.77 333,442 2007-10-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 10.38 69,512 2007-10-01 Eberhard Craig A (VP Sales) Sale 1,000 49.67 49,670 2007-10-01 Eberhard Craig A (VP Sales) Option Exercise 1,000 18.85 18,850 2007-10-01 Baron Alain D (Sr VP Research) Sale 3,000 49.81 149,437 2007-10-01 Baron Alain D (Sr VP Research) Option Exercise 3,000 7.19 21,562 2007-10-01 Greene Howard E Jr (Director) Sale 3,700 49.54 183,286 2007-09-28 Foletta Mark G (Senior VP, Finance & CFO) Sale 3,000 49.98 149,931 2007-09-28 Foletta Mark G (Senior VP, Finance & CFO) Option Exercise 3,000 13.25 39,750 2007-09-26 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 50.00 250,000 2007-09-26 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 5.73 28,650 2007-09-18 Baron Alain D (Sr VP Research) Sale 1,000 47.75 47,750 2007-09-18 Baron Alain D (Sr VP Research) Option Exercise 1,000 7.19 7,187 2007-09-18 Cook Joseph C Jr (Director) Sale 10,000 47.56 475,590 2007-09-17 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 48.74 243,710 2007-09-17 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 5.73 28,650 2007-09-17 Greene Howard E Jr (Director) Sale 3,700 47.88 177,147 2007-09-05 Graham Ginger L (Executive Advisor) Option Exercise 1,450 19.77 28,666 2007-09-04 Gergen Mark J (Sr VP, Corporate Development) Sale 1,000 49.50 49,500 2007-09-04 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 1,000 16.80 16,800 2007-09-04 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 48.99 97,988 2007-09-04 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Exercise 2,000 20.72 41,450 2007-09-04 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 48.97 328,113 2007-09-04 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 9.62 64,487 2007-09-04 Eberhard Craig A (VP Sales) Sale 1,000 48.99 48,994 2007-09-04 Eberhard Craig A (VP Sales) Option Exercise 1,000 18.85 18,850 2007-09-04 Baron Alain D (Sr VP Research) Sale 4,000 49.50 198,000 2007-09-04 Baron Alain D (Sr VP Research) Option Exercise 4,000 7.19 28,750 2007-09-04 Cook Joseph C Jr (Director) Sale 10,000 49.49 494,918 2007-09-04 Greene Howard E Jr (Director) Sale 3,700 49.50 183,160 2007-08-31 Foletta Mark G (Senior VP, Finance & CFO) Sale 3,000 48.86 146,574 2007-08-31 Foletta Mark G (Senior VP, Finance & CFO) Option Exercise 3,000 13.25 39,750 2007-08-20 Baron Alain D (Sr VP Research) Sale 1,000 49.00 49,000 2007-08-20 Baron Alain D (Sr VP Research) Option Exercise 1,000 11.12 11,125 2007-08-20 Greene Howard E Jr (Director) Sale 3,700 48.92 180,995 2007-08-17 Cook Joseph C Jr (Director) Sale 100 47.65 4,765 2007-08-16 Cook Joseph C Jr (Director) Sale 9,900 48.26 477,805 2007-08-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 10,000 49.10 491,003 2007-08-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 10,000 14.28 142,810 2007-08-08 Baron Alain D (Sr VP Research) Sale 1,000 53.00 53,000 2007-08-08 Baron Alain D (Sr VP Research) Option Exercise 1,000 7.19 7,187 2007-08-08 Wilson James N (Director) Sale 3,334 51.44 171,515 2007-08-08 Graham Ginger L (Executive Advisor) Sale 23,000 51.33 1,180,662 2007-08-08 Graham Ginger L (Executive Advisor) Option Exercise 23,000 13.14 302,296 2007-08-07 Gergen Mark J (Sr VP, Corporate Development) Sale 500 50.00 25,000 2007-08-07 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400 2007-08-07 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 50.00 250,000 2007-08-07 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 14.28 71,405 2007-08-07 Baron Alain D (Sr VP Research) Sale 1,000 50.00 50,000 2007-08-07 Baron Alain D (Sr VP Research) Option Exercise 1,000 7.19 7,187 2007-08-07 Wilson James N (Director) Sale 5,334 50.11 267,261 2007-08-07 Graham Ginger L (Executive Advisor) Sale 10,000 50.51 505,101 2007-08-07 Graham Ginger L (Executive Advisor) Option Exercise 10,000 10.25 102,500 2007-08-06 Graham Ginger L (Executive Advisor) Sale 10,000 49.50 495,013 2007-08-06 Graham Ginger L (Executive Advisor) Option Exercise 10,000 4.38 43,750 2007-08-06 Greene Howard E Jr (Director) Sale 3,846 48.67 187,189 2007-08-02 Cook Joseph C Jr (Director) Sale 100 46.63 4,663
Go to page: 1
2 3 4
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of AMYLIN PHARMACEUTICALS INC (symbol AMLN ,
CIK number 881464 ) see
the Securities and Exchange Commission (SEC) website.
